1. How does your institution handle teaching/transitions of care for patients being discharged on insulin pens? For example:

a. Are insulin pens available in the hospital pharmacy for teaching prior to discharge?
b. Are insulin demo pens available in the hospital for teaching prior to discharge?
c. Are insulin pens procured from outpatient/retail pharmacy (brown-bagged) for teaching prior to discharge?
d. Other (please explain)
e. None of the above

RE: Best practice 20, would greatly appreciate lessons learned from folks that have transitioned to primarily premixed Tranexamic acid bags in their peri-operative spaces.

Specifically, did you encounter any challenges related to tranexamic acid topical use? Did you leave vials available in a restricted manner? Any other helpful tips.

Thanks,
Paul

Hi,

We have a few questions regarding airway carts and neuromuscular blocker storage.
1. Does your organization have airway carts in perioperative areas?
2. Do your organization's airway carts contain medication, specifically neuromuscular blockers (NMB)?
3. If your airway carts contain NMB, how are they stored and monitored?

Thank you!
Gabriella Philipson, PharmD

Good morning,

I wanted to query if your state allows technicians to access the prescription monitoring system for controlled substances. Would you be able to provide the below details?
- Does your state allow techs to access the PMP? if so, which state are you located?
- Do they have additional credential requirements/training required before they can get access?
- Do they have a limited access/view or can they view everything?
- Are you able to have this integrated into the EMR for them?

We have a request to place all anticoagulant IV medications in a red bag in order to identify them more easily on the nursing side.

I have logistical concerns and general concerns with this process (relying on a manual process and color coding). Has anyone here used this type of process for anticoagulants? What have you seen work on the nursing side to more easily identify anticoagulants?

Hello,
We are preparing for a Joint Commission visit and working on USP <797> compliance in ORs/procedural areas. We are hoping you would be willing to share information about your sterile product practices in these areas and any recent experience with TJC surveyors on this topic.
- Do you consider preparing sterile products in ORs/procedural areas (Examples: drawing up a dose from a vial, drawing propofol into a syringe, etc.) to be immediate-use compounding or per approved labeling?

How do you safeguard against wrong route med administration errors in the OR for topical meds. Specifically thinking of thrombin, but interested in other topical medications as well if you have strategies in place.

Thank you!

Sloane Hoefer
Nebraska Medicine

What is the policy or clinical practice for the management of patients experiencing rigors/chills as a manifestation of a hypersensitivity reaction to treatment involving anti-CD20 directed treatment (ie. rituximab, obinutuzumab)?

Good Morning All,

Currently our smart pump drug library entry for parenteral nutrition is built with an infusion rate soft max. We have a request to modify the entry to include a hard max. I'm curious if others have built their parenteral nutrition entries with a hard max and what that limit is. Does that hard max differ for central vs. peripheral administration?

Thanks in advance!

Dear Colleagues

I hope this message find you all well , i'm exploring best practice for documenting medication removal and administration in the operating room

our current practice , there is pyxis (non profile) there and they remove the medications by patient and there is no order in the HIS

Im looking to learn how other institutions adress this issue

your input would be invaluable in helping us improve our practice and patient safety outcones

thank you